Agonist-mediated activation of STING induces apoptosis in malignant B cells

Cancer Research

Volumn 76, Issue 8, 2016, Pages 2137-2152

  Tang, Chih Hang Anthony ^a   Zundell, Joseph A ^a   Ranatunga, Sujeewa ^b   Lin, Cindy ^a   Nefedova, Yulia ^a   Del Valle, Juan R ^b   Hu, Chih Chi Andrew ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3'3' CGAMP; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; MEMBRANE PROTEIN; STING PROTEIN; STING PROTEIN AGONIST; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; CYCLIC GMP; MPYS PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER IMMUNOLOGY; CANCER REGRESSION; CELL STIMULATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; LEUKEMIA CELL; MITOCHONDRION; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; TREATMENT RESPONSE; AGONISTS; ANIMAL; B LYMPHOCYTE; CELL LINE; CYTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; CYCLIC GMP; INJECTIONS, INTRAPERITONEAL; MEMBRANE PROTEINS; MICE;

EID: 84970963467     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1885     Document Type: Article

References (50)

1. WuJX, Sun LJ, Chen X, Du FH, Shi HP, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013;339:826-30.
2. Sun LJ, Wu JX, Du FH, Chen X, Chen ZJJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013;339:786-91.
3. Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, Hyodo M, et al. The innate immuneDNAsensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 2013;3:1355-61.
4. Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Rohl I, et al. cGAS produces a 20-50-linked cyclic dinucleotide second messenger that activates STING. Nature 2013;498:380-4.
5. Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 2013;51:226-35.
6. Jin L, Hill KK, Filak H, Mogan J, Knowles H, Zhang B, et al. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol 2011;187:2595-601.
7. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011;478:515-8.
8. Yin Q, Tian Y, Kabaleeswaran V, Jiang X, Tu D, Eck MJ, et al. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol Cell 2012;46:735-45.
9. Gao P, Ascano M, Zillinger T, Wang W, Dai P, Serganov AA, et al. Structurefunction analysis of STING activation by c[G(20,50)pA(30,50)p] and targeting by antiviral DMXAA. Cell 2013;154:748-62.
10. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008;455:674-8.
11. Sun W, Li Y, Chen L, Chen H, You F, Zhou X, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci U S A 2009;106:8653-8.
12. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008;29:538-50.
13. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNAmediated, type I interferon-dependent innate immunity. Nature 2009;461: 788-92.
14. Chen W, Kuolee R, Yan H. The potential of 30,50-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine 2010;28:3080-5.
15. Dubensky TW Jr, Kanne DB, Leong ML. Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants. Ther Adv Vaccines 2013;1:131-43.
16. Fu J, Kanne DB, Leong M, Glickman LH, McWhirter SM, Lemmens E, et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Translat Med 2015;7:283ra52.
17. Deng L, Liang H, XuM, Yang X, Burnette B, Arina A, et al. STING-Dependent Cytosolic DNA sensing promotes radiation-induced type I interferondependent antitumorimmunity inimmunogenic tumors. Immunity 2014; 41:843-52.
18. Baguley BC, Ching LM. DMXAA: an antivascular agent with multiple host responses. Int J Radiation Oncol Biol Phys 2002;54:1503-11.
19. Philpott M, Baguley BC, Ching LM. Induction of tumour necrosis factoralpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol 1995;36:143-8.
20. Woon ST, Reddy CB, Drummond CJ, Schooltink MA, Baguley BC, Kieda C, et al. A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines. Oncol Res 2005; 15:351-64.
21. Taylor JL, Schoenherr CK, Grossberg SE. High-yield interferon induction by 10-carboxymethyl-9-acridanone inmice and hamsters. Antimicrob Agents Chemother 1980;18:20-6.
22. Storch E, Kirchner H. Induction of interferon in murine bone marrowderived macrophage cultures by 10-carboxymethyl-9-acridanone. Eur J Immunol 1982;12:793-6.
23. Cavlar T, Deimling T, Ablasser A, Hopfner KP, Hornung V. Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J 2013;32:1440-50.
24. Gao P, Zillinger T,Wang W, Ascano M, Dai P, Hartmann G, et al. Bindingpocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA. Cell Rep 2014;8:1668-76.
25. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-29.
26. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011;334:1081-6.
27. Shen X, Ellis RE, Lee K, Liu CY, Yang K, Solomon A, et al. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 2001;107:893-903.
28. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001;107:881-91.
29. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002;415:92-6.
30. Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Zhang C, Shokat KM, et al. The unfolded protein response signals through high-order assembly of Ire1. Nature 2009;457:687-93.
31. Sriburi R, Jackowski S, Mori K, Brewer JW. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J Cell Biol 2004;167:35-41.
32. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003;23:7448-59.
33. McGehee AM, Dougan SK, Klemm EJ, Shui G, Park B, Kim YM, et al. XBP-1-deficient plasmablasts show normal protein folding but altered glycosylation and lipid synthesis. J Immunol 2009;183:3690-9.
34. ReimoldAM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, et al. Plasma cell differentiation requires the transcription factor XBP-1. Nature 2001;412:300-7.
35. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 2003;4:321-9.
36. Hu CC, Dougan SK, McGehee AM, Love JC, Ploegh HL. XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells. EMBO J 2009;28:1624-36.
37. Zhang K, Wong HN, Song B, Miller CN, Scheuner D, Kaufman RJ. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest 2005;115:268-81.
38. Tang CH, Ranatunga S, Kriss CL, Cubitt CL, Tao J, Pinilla-Ibarz JA, et al. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J Clin Invest 2014;124:2585-98.
39. Gaffney BL, Veliath E, Zhao J, Jones RA. One-flask syntheses of c-di-GMP and the [Rp,Rp] and [Rp,Sp] thiophosphate analogues. Organic Lett 2010;12:3269-71.
40. Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, et al. Cyclic [G(20,50)pA(30,50)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 2013;153:1094-107.
41. Kim S, Li L,Maliga Z, YinQ,WuH,Mitchison TJ. Anticancer flavonoids are mouse-selective STING agonists. ACS Chem Biol 2013;8:1396-401.
42. Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol 2013;190:5216-25.
43. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 2002;99:6955-60.
44. Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, et al. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood 2012;120:1027-38.
45. Luo D, He Y, Zhang H, Yu L, Chen H, Xu Z, et al. AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. J Biol Chem 2008;283:11905-12.
46. Papandreou I, Denko NC, OlsonM, VanMelckebeke H, Lust S, Tam A, et al. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 2011;117:1311-4.
47. Kharabi Masouleh B, Geng H, Hurtz C, Chan LN, Logan AC, Chang MS, et al. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 2014;111: E2219-28.
48. Hu CC, Dougan SK, Winter SV, Paton AW, Paton JC, Ploegh HL. Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes. J Exp Med 2009;206:2429-40.
49. Zeng M, Hu Z, Shi X, Li X, Zhan X, Li XD, et al. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 2014;346:1486-92.
50. Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 2014;41:830-42.